FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377011791> ?p ?o ?g. }

• W4377011791 abstract "Treatment options for patients with secondary and myeloid related changes acute myeloid leukemia (sAML and AML-MRC) aged 60-75 years old are scarce and unsuitable. A pivotal trial showed that CPX-351 improved complete remission with/without incomplete recovery (CR/CRi) and overall survival (OS) as compared with standard 3+7. We retrospectively analyze outcomes of 765 patients with sAML and AML-MRC aged 60-75 years treated with intensive chemotherapy (IC), reported to the PETHEMA registry before CPX-351 became available. The CR/CRi rate was 48%, median OS 7.6 months (CI95%, 6.7-8.5) and event-free survival (EFS) 2.7 months (CI95%, 2-3.3), without differences between IC regimens and AML type. Multivariate analyses identified age ≥70 years, ECOG≥1 as independent adverse prognostic factors for CR/CRi and OS, while favorable/intermediate cytogenetic risk and NPM1 were favorable prognostic factors. Patients receiving allogeneic stem cell transplant (HSCT), auto-HSCT, and those who completed more consolidation cycles showed improved OS. This large study suggests that classical intensive chemotherapy could lead to similar CR/CRi rates with slightly shorter median OS than CPX-351." @default.
• W4377011791 created "2023-05-19" @default.
• W4377011791 creator A5000630840 @default.
• W4377011791 creator A5002155891 @default.
• W4377011791 creator A5003682435 @default.
• W4377011791 creator A5003692798 @default.
• W4377011791 creator A5006641410 @default.
• W4377011791 creator A5009262129 @default.
• W4377011791 creator A5010010012 @default.
• W4377011791 creator A5011914281 @default.
• W4377011791 creator A5015222482 @default.
• W4377011791 creator A5015992357 @default.
• W4377011791 creator A5021641803 @default.
• W4377011791 creator A5023845542 @default.
• W4377011791 creator A5024908600 @default.
• W4377011791 creator A5025193090 @default.
• W4377011791 creator A5031060735 @default.
• W4377011791 creator A5032350240 @default.
• W4377011791 creator A5032617188 @default.
• W4377011791 creator A5036778361 @default.
• W4377011791 creator A5052872662 @default.
• W4377011791 creator A5053626099 @default.
• W4377011791 creator A5058471745 @default.
• W4377011791 creator A5058799782 @default.
• W4377011791 creator A5062939189 @default.
• W4377011791 creator A5063637476 @default.
• W4377011791 creator A5064234669 @default.
• W4377011791 creator A5069030466 @default.
• W4377011791 creator A5069427718 @default.
• W4377011791 creator A5069753479 @default.
• W4377011791 creator A5073187131 @default.
• W4377011791 creator A5074070184 @default.
• W4377011791 creator A5074938601 @default.
• W4377011791 creator A5077745882 @default.
• W4377011791 creator A5079032857 @default.
• W4377011791 creator A5085969689 @default.
• W4377011791 creator A5089501338 @default.
• W4377011791 date "2023-05-18" @default.
• W4377011791 modified "2023-10-17" @default.
• W4377011791 title "Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry" @default.
• W4377011791 doi "https://doi.org/10.3324/haematol.2022.282506" @default.
• W4377011791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37199127" @default.
• W4377011791 hasPublicationYear "2023" @default.
• W4377011791 type Work @default.
• W4377011791 citedByCount "0" @default.
• W4377011791 crossrefType "journal-article" @default.
• W4377011791 hasAuthorship W4377011791A5000630840 @default.
• W4377011791 hasAuthorship W4377011791A5002155891 @default.
• W4377011791 hasAuthorship W4377011791A5003682435 @default.
• W4377011791 hasAuthorship W4377011791A5003692798 @default.
• W4377011791 hasAuthorship W4377011791A5006641410 @default.
• W4377011791 hasAuthorship W4377011791A5009262129 @default.
• W4377011791 hasAuthorship W4377011791A5010010012 @default.
• W4377011791 hasAuthorship W4377011791A5011914281 @default.
• W4377011791 hasAuthorship W4377011791A5015222482 @default.
• W4377011791 hasAuthorship W4377011791A5015992357 @default.
• W4377011791 hasAuthorship W4377011791A5021641803 @default.
• W4377011791 hasAuthorship W4377011791A5023845542 @default.
• W4377011791 hasAuthorship W4377011791A5024908600 @default.
• W4377011791 hasAuthorship W4377011791A5025193090 @default.
• W4377011791 hasAuthorship W4377011791A5031060735 @default.
• W4377011791 hasAuthorship W4377011791A5032350240 @default.
• W4377011791 hasAuthorship W4377011791A5032617188 @default.
• W4377011791 hasAuthorship W4377011791A5036778361 @default.
• W4377011791 hasAuthorship W4377011791A5052872662 @default.
• W4377011791 hasAuthorship W4377011791A5053626099 @default.
• W4377011791 hasAuthorship W4377011791A5058471745 @default.
• W4377011791 hasAuthorship W4377011791A5058799782 @default.
• W4377011791 hasAuthorship W4377011791A5062939189 @default.
• W4377011791 hasAuthorship W4377011791A5063637476 @default.
• W4377011791 hasAuthorship W4377011791A5064234669 @default.
• W4377011791 hasAuthorship W4377011791A5069030466 @default.
• W4377011791 hasAuthorship W4377011791A5069427718 @default.
• W4377011791 hasAuthorship W4377011791A5069753479 @default.
• W4377011791 hasAuthorship W4377011791A5073187131 @default.
• W4377011791 hasAuthorship W4377011791A5074070184 @default.
• W4377011791 hasAuthorship W4377011791A5074938601 @default.
• W4377011791 hasAuthorship W4377011791A5077745882 @default.
• W4377011791 hasAuthorship W4377011791A5079032857 @default.
• W4377011791 hasAuthorship W4377011791A5085969689 @default.
• W4377011791 hasAuthorship W4377011791A5089501338 @default.
• W4377011791 hasBestOaLocation W43770117911 @default.
• W4377011791 hasConcept C104317684 @default.
• W4377011791 hasConcept C126322002 @default.
• W4377011791 hasConcept C141071460 @default.
• W4377011791 hasConcept C143998085 @default.
• W4377011791 hasConcept C167135981 @default.
• W4377011791 hasConcept C185592680 @default.
• W4377011791 hasConcept C2483381 @default.
• W4377011791 hasConcept C2776694085 @default.
• W4377011791 hasConcept C2778336483 @default.
• W4377011791 hasConcept C2778729363 @default.
• W4377011791 hasConcept C30481170 @default.
• W4377011791 hasConcept C53226629 @default.
• W4377011791 hasConcept C55493867 @default.
• W4377011791 hasConcept C71924100 @default.
• W4377011791 hasConceptScore W4377011791C104317684 @default.
• W4377011791 hasConceptScore W4377011791C126322002 @default.
• W4377011791 hasConceptScore W4377011791C141071460 @default.
• W4377011791 hasConceptScore W4377011791C143998085 @default.

• next